Wuhan GeneCreate Biological Engineering Co., Ltd. (hereinafter referred to as GeneCreate) is established in the July of 2013. Located in the building 4 of Biological Innovation Park in Wuhan National Bio-industry Base, GeneCreate has engaged in providing biological technical service for global customers.

GeneCreate has a development workshop of 2000 square meters. With more than 50 professional and technical personnel, our company has expanded its business line to primer synthesis, gene synthesis, the five system recombinant protein expression (escheria coli, bacillus subtilis, yeast, insect cell and mammalian cell), monoclonal and polyclonal antibody preparation, small molecule antigen synthesis, immunology testing services (ELISA,WB,IHC,ICC,IP), diagnostic kit development, drug screening service and proteomics service （iTRAQ、lable-free、SWATH）. Our service covers the major areas of life science research and GeneCreate is aiming at doing its best to provide service for the world’s large pharmaceutical companies, diagnostic products corporations, scientific research reagents development companies, university research institutes and hospital clinical departments etc.